BTSG Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
3.9B
+7.2%
3.6B
+1.8%
3.6B
+6.5%
3.3B
+5.9%
3.1B
Cost of Revenue
3.4B
+7.9%
3.1B
-0.2%
3.1B
+6.7%
2.9B
+6.1%
2.8B
Gross Profit
492.7M
+2.2%
482.2M
+16.9%
412.5M
+5.2%
392.0M
+4.6%
374.9M
Operating Expenses
362.4M
+0.4%
360.8M
+18.5%
304.4M
+0.1%
304.2M
-6.8%
326.3M
R&D
0
0
0
0
0
SG&A
362.4M
+0.4%
360.8M
+18.5%
304.4M
+0.1%
304.2M
-6.8%
326.3M
Operating Income
130.4M
+7.4%
121.4M
+12.3%
108.1M
+23.1%
87.8M
+80.9%
48.6M
EBITDA
171.8M
+7.0%
160.5M
+8.7%
147.6M
+14.8%
128.6M
+42.3%
90.4M
Net Income
84.2M
-43.3%
148.6M
+92.2%
77.3M
+40.0%
55.2M
+100.6%
27.5M
EPS (Basic)
$0.41
-43.8%
$0.73
+92.1%
$0.38
+40.7%
$0.27
+92.9%
$0.14
EPS (Diluted)
$0.38
-43.3%
$0.67
+97.1%
$0.34
+30.8%
$0.26
+100.0%
$0.13
Shares (Diluted)
220.3M
-0.5%
221.3M
-3.7%
229.9M
+5.4%
218.0M
+0.8%
216.3M
BrightSpring Health Services (BTSG) โ€” Financials